Nanoparticle formulation may affect the stabilization of an antiischemic prodrug.
about
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheresDevelopment and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid.Intranasal therapeutic strategies for management of Alzheimer's disease.Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation.The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticles on mucoadhesion due to pluronic F68 addition.Bovine Serum Albumin-Loaded Chitosan/Dextran Nanoparticles: Preparation and Evaluation ofEx VivoColloidal Stability in Serum
P2860
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug.
@ast
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug.
@en
type
label
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug.
@ast
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug.
@en
prefLabel
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug.
@ast
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug.
@en
P2093
P50
P1476
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug
@en
P2093
Bortolotti F
Scatturin A
P304
P356
10.1016/J.IJPHARM.2005.09.031
P407
P577
2005-11-14T00:00:00Z